Chemistry:3F-NEB

From HandWiki

3-Fluoro-N-ethylbuphedrone (3F-NEB) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug.[1] It was first identified in Sweden in 2021.[2][3]

Pharmacology

Pharmacodynamics

In vivo, 3F-NEB acts as a potent inhibitor of the dopamine transporter, exhibiting more than 100-fold selectivity over the serotonin transporter. Administration of 3 milligrams rapidly increased extracellular dopamine levels in the nucleus accumbens, of the rat. At the behavioural level, 3F-NEB caused a dose-dependent increase in motor activity at doses of 10–30 mg/kg, with the highest doses inducing anxiety-like effects.[1]

See also

References

  1. ↑ 1.0 1.1 "Neurochemical and behavioral evidence of high abuse liability of 3F-NEB, a novel synthetic cathinone". European Journal of Pharmacology 1015. February 2026. doi:10.1016/j.ejphar.2026.178570. PMID 41554370. 
  2. ↑ European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System. European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/396103. ISBN 978-92-9497-737-3. 
  3. ↑ "A review of synthetic cathinones emerging in recent years (2019-2022)". Forensic Toxicology 41 (1): 25–46. September 2022. doi:10.1007/s11419-022-00639-5. PMID 36124107.